Grandpa and I have dystrophinopathy?: approach to asymptomatic hyperCKemia.

[1]  Thomas W Prior,et al.  Experience and strategy for the molecular testing of Duchenne muscular dystrophy. , 2005, The Journal of molecular diagnostics : JMD.

[2]  C. Bönnemann.  Limb-girdle muscular dystrophy in childhood. , 2005, Pediatric annals.

[3]  S. Dimauro,et al.  Differentiating idiopathic inflammatory myopathies from metabolic myopathies. , 2002, Rheumatic diseases clinics of North America.

[4]  B. Darras,et al.  Metabolic myopathies: a clinical approach; part II. , 2000, Pediatric neurology.

[5]  R. Pourmand.  METABOLIC MYOPATHIES: A Diagnostic Evaluation , 2000 .

[6]  C. Doriguzzi,et al.  Dystrophinopathy expressing as either cardiomyopathy or Becker dystrophy in the same family , 2000, Neurology.

[7]  G. Danieli,et al.  Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. , 1996, Circulation.

[8]  L. Morandi,et al.  DMD and BMD in the same family due to two distinct mutations , 1995 .

[9]  J. Faulkner,et al.  Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. , 1995, Human molecular genetics.

[10]  K. Campbell,et al.  Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform. , 1994, Human molecular genetics.

[11]  N. Bresolin,et al.  Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates. , 1994, Brain : a journal of neurology.

[12]  K. Bushby,et al.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis. , 1993, Journal of medical genetics.

[13]  D. Wedel.  Malignant hyperthermia and neuromuscular disease , 1992, Neuromuscular Disorders.

[14]  H Sugita,et al.  Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. , 1991, American journal of human genetics.

[15]  L. Kunkel,et al.  Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction , 1990, Human Genetics.

[16]  C. Pearson,et al.  Serum enzyme alterations in neuromuscular disorders. , 1973, JAMA.

[17]  R. Leshner.  Genotype-phenotype correlations in hereditary muscle diseases. Implications for diagnosis and treatment. , 2004, Supplements to Clinical neurophysiology.

[18]  Susan C. Brown,et al.  Chapter 31 Immunopathology and molecular genetics of dystrophinopathies , 2004 .

[19]  G. Miller,et al.  Diagnosis of dystrophinopathies: review for the clinician. , 1993, Pediatric neurology.